19375874

Source:http://linkedlifedata.com/resource/pubmed/id/19375874

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0032633, umls-concept:C0497062, umls-concept:C0677850
pubmed:issue	2
pubmed:dateCreated	2009-5-27
pubmed:abstractText	Manifestations of dyshidrotic eczema can be alleviated by exposure to medium and high doses of ultraviolet A1 (UVA1) radiation. Since the induction of apoptosis of T cells by UVA1, as the basic mechanism of therapy, is proportional to the dose of radiation it is to be expected that in mild cases or for maintenance therapy low doses of radiation will also be effective. UVA1 radiation is a constituent of sunlight, so exposure to sunlight could prove beneficial in treating dyshidrotic eczema.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/7505668
pubmed:citationSubset	IM
pubmed:status	MEDLINE
pubmed:month	Aug
pubmed:issn	1532-2777
pubmed:author	pubmed-author:Leti?MiloradM
pubmed:issnType	Electronic
pubmed:volume	73
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	203-4
pubmed:meshHeading	pubmed-meshheading:19375874-Eczema, Dyshidrotic, pubmed-meshheading:19375874-Humans, pubmed-meshheading:19375874-Sunlight
pubmed:year	2009
pubmed:articleTitle	Exposure to sunlight as adjuvant therapy for dyshidrotic eczema.
pubmed:affiliation	Department of Biophysics, School of Medicine, University of Belgrade, Visegradska 26/II, 11 000 Beograd, Republic of Serbia. milet@rcub.bg.ac.yu
pubmed:publicationType	Journal Article